Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1988 August; 58(2): 163–170.
PMCID: PMC2246757

The effect of age and menstrual cycle upon proliferative activity of the normal human breast.


The aim of this study was to determine the proliferative activity within the epithelial cells of the normal human breast in 122 patients (6 reduction mammoplasties and 116 fibroadenoma excisions) in relation to age and the phase of the menstrual cycle. Thirty three of the patients were on oral contraceptives and 33 were parous. Thin tissue slices were incubated with tritiated thymidine and processed for autoradiography. Other samples were fixed directly and prepared for histology. The labelling, mitotic and apoptotic indices (LI, MI and AI) were determined and all illustrated considerable variability. The labelling indices are significantly (P less than 0.05) influenced by both patient age and stage during the menstrual cycle and ranged from 0-11.5%. Maximum LI values were obtained on the 20.8th day of the cycle. A square root transformation of the data was used to reduce the skewness of the data to a more normal distribution. The square root of the LI declined by 0.22 per decade. The mitotic data showed similar significant (P less than 0.05) correlations against age and day of cycle with a peak on the 21.5th day of the cycle, a decline by 0.072 per decade and a range from 0-0.6%. The data for apoptotic cells were less clearly influenced by the stage of the menstrual cycle but showed a significant (P less than 0.5) decline with age. The AI in parous patients was significantly higher than that in non-parous patients. There was no significant effect of oral contraceptives on any of the parameters measured when age and stage of cycle were taken into account. The considerable variability in the data could not be fully accounted for by either technical factors, the age of the patients, or the day of the cycle. We conclude that proliferation is negatively related to age and is influenced by the menstrual cycle but that additional as yet unknown factors must account for a large part of the variability seen in the data.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Anderson TJ, Ferguson DJ, Raab GM. Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer. 1982 Sep;46(3):376–382. [PMC free article] [PubMed]
  • Braunsberg HA, Coldham NG, Wong W. Hormonal therapies for breast cancer: can progestogens stimulate growth? Cancer Lett. 1986 Feb;30(2):213–218. [PubMed]
  • Ferguson DJ, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer. 1981 Aug;44(2):177–181. [PMC free article] [PubMed]
  • Ferguson DJ, Anderson TJ. Ultrastructural observations on cell death by apoptosis in the "resting" human breast. Virchows Arch A Pathol Anat Histol. 1981;393(2):193–203. [PubMed]
  • Flaxman BA, Lasfargues EY. Hormone-independent DNA synthesis by epithelial cells of adult human mammary gland in organ culture. Proc Soc Exp Biol Med. 1973 Jun;143(2):371–374. [PubMed]
  • Going JJ, Anderson TJ, Battersby S, MacIntyre CC. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol. 1988 Jan;130(1):193–204. [PubMed]
  • Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk? Cancer. 1985 Sep 1;56(5):1206–1208. [PubMed]
  • Hissom JR, Moore MR. Progestin effects on growth in the human breast cancer cell line T-47D--possible therapeutic implications. Biochem Biophys Res Commun. 1987 Jun 15;145(2):706–711. [PubMed]
  • Horwitz KB, Freidenberg GR. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies. Cancer Res. 1985 Jan;45(1):167–173. [PubMed]
  • Klevjer-Anderson P, Buehring GC. Effect of hormones on growth rates of malignant and nonmalignant human mammary epithelia in cell culture. In Vitro. 1980 Jun;16(6):491–501. [PubMed]
  • Korenman SG. The endocrinology of breast cancer. Cancer. 1980 Aug 15;46(4 Suppl):874–878. [PubMed]
  • Land CE, Boice JD, Jr, Shore RE, Norman JE, Tokunaga M. Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. J Natl Cancer Inst. 1980 Aug;65(2):353–376. [PubMed]
  • La Vecchia C, Decarli A, di Pietro S, Franceschi S, Negri E, Parazzini F. Menstrual cycle patterns and the risk of breast disease. Eur J Cancer Clin Oncol. 1985 Apr;21(4):417–422. [PubMed]
  • Leung BS, Potter AH, Qureshi S. Interaction of prolactin, estrogen and progesterone in a human mammary carcinoma cell line, CAMA-1 - I Cell growth and thymidine uptake. J Steroid Biochem. 1981 Dec;15:421–427. [PubMed]
  • Longacre TA, Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol. 1986 Jun;10(6):382–393. [PubMed]
  • Longman SM, Buehring GC. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth. Cancer. 1987 Jan 15;59(2):281–287. [PubMed]
  • MacMahon B, Cole P, Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst. 1973 Jan;50(1):21–42. [PubMed]
  • McManus MJ, Welsch CW. The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer. 1984 Nov 1;54(9):1920–1927. [PubMed]
  • Masters JR, Drife JO, Scarisbrick JJ. Cyclic Variation of DNA synthesis in human breast epithelium. J Natl Cancer Inst. 1977 May;58(5):1263–1265. [PubMed]
  • Mauvais-Jarvis P, Kuttenn F, Gompel A. Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat. 1986;8(3):179–188. [PubMed]
  • Murphy LJ, Murphy LC, Stead B, Sutherland RL, Lazarus L. Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. J Clin Endocrinol Metab. 1986 Feb;62(2):280–287. [PubMed]
  • Murphy LJ, Sutherland RL, Stead B, Murphy LC, Lazarus L. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res. 1986 Feb;46(2):728–734. [PubMed]
  • Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. [PubMed]
  • Russo J, Calaf G, Roi L, Russo IH. Influence of age and gland topography on cell kinetics of normal human breast tissue. J Natl Cancer Inst. 1987 Mar;78(3):413–418. [PubMed]
  • Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 1982;2(1):5–73. [PubMed]
  • Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS., Jr The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol. 1981 Jul;104(1):23–34. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK